EMD-39557

Single-particle
3.03 Å
EMD-39557
3D View Gallery
Deposition: 22/03/2024
Map released: 02/07/2025
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-39557
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8ys6 summary report (pdf.gz) Map and 8ys6 FULL report (pdf.gz)
EMICSS annotations (xml)

Helicobacter pylori OorDABC in complex with Napabucasin

EMD-39557

Single-particle
3.03 Å
EMD-39557
3D View Gallery
Deposition: 22/03/2024
Map released: 02/07/2025
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Helicobacter pylori
Sample: Helicobacter pylori OorDABC in complex with Napabucasin
Fitted models: 8ys6

Deposition Authors: Lan W, Gao Y, Bi H
2-oxoglutarate:acceptor oxidoreductase-catalyzed redox cycling effectively targets coccoid forms of Helicobacter pylori.
Hang X, Lan W, Yanqiang H, Huang H, Zhang M, Zeng L, Shi T, Bai Y, Yang Z, Hu S, Wang J, Dong L, Tong Q, Jia J, Bi S, Xia Q, Gao Y, Bi H
(2025) Nat Commun , 16 , 6965 - 6965
PUBMED: 40730563
DOI: doi:10.1038/s41467-025-62477-4
ISSN: 2041-1723